The sumatriptan nasal spray: A review of clinical trials

Cephalalgia, Supplement

Volumn 21, Issue 1, 2001, Pages 13-15

  Rapoport, A ^a  

^a NEW ENGLAND CENTER FOR HEADACHE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROERGOTAMINE; PLACEBO; SUMATRIPTAN;

ANALGESIA; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HUMAN; MIGRAINE; NAUSEA; PHOTOPHOBIA; RECURRENT DISEASE; SHORT SURVEY; SIDE EFFECT; THROAT DISEASE; TREATMENT OUTCOME; VERTIGO; VOMITING;

EID: 0035741375     PISSN: 08001952     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2001.021s1013.x     Document Type: Short Survey

References (6)

1. Sumatriptan nasal spray in the acute treatment of migraine: A review of clinical studies
2. Sumatriptan nasal spray. A dose-ranging study in the acute treatment of migraine
3. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies
4. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine
5. A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine